课题基金 / 基金详情

DISTINCTION AMONG EIGHT OPIATE DRUGS IN URINE BY GAS CHROMATOGRAPHIC

DISTINCTION AMONG EIGHT OPIATE DRUGS IN URINE BY GAS CHROMATOGRAPHIC
通过气相色谱法区分尿液中的八种阿片类药物
批准号:
6665871
负责人:
WILLIAM NOWATZKE
金额:
$15.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2003-07-31

项目摘要

项目成果

WILLIAM NOWATZKE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Opiates are commonly abused substances, and forensic urine drug-testing for them involves an immunoassay screen and gas chromatographic/mass spectrometric (GC/MS) confirmation. There are also medical reasons to test urine for opiates, and confirmation procedures other than GC/MS are often used for medical drug-testing which are more compatible with the demands of clinical services and which identify a wider range of opiates than those in standard forensic batteries. One such procedure involves thin-layer chromatographic (TLC) analysis of opiate derivatives and can distinguish eight clinically encountered opiates, including morphine, acetylmorphine, hydromorphone, oxymorphone, codeine, dihydrocodeine, hydrocodone, and oxycodone. Medical drug-testing results are sometimes challenged by patients, causing physicians to request additional confirmation of the identified opiates. To our knowledge, no previous report examines all opiates specified above in a single GC/MS pr ocedure, but we find that they can be distinguished by GC/MS analyses of trimethylsilyl (TMS) ether derivatives, the mass spectra of which contain prominent molecular ions. Inclusion of deuterium-labeled internal standards permits quantitation of each of the eight opiates in urine. The GC/MS assay is linear over a concentration range which spans the TLC cutoff level, and coefficients of variation of 10% or less at concentrations below the TLC cutoff are achieved by for all opiates specified above except for oxymorphone and oxycodone, which exhibit coefficients of variation of 18-19%. This procedure has proved useful as a third-stage identification step for medical drug-testing specimens in which results from prior immunoassay and TLC analyses were challenged.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MASS SPECTROMETRIC EVIDENCE AGENTS WHICH CAUSE CA2+ LOSS
  • 批准号:
    6665870
  • 项目类别:
  • 资助金额:
    $15.75万
  • 财政年份:
    2002
  • 负责人:
    WILLIAM NOWATZKE
  • 依托单位:
MASS SPECTROMETRIC EVIDENCE AGENTS WHICH CAUSE CA2+ LOSS
  • 批准号:
    6486750
  • 项目类别:
  • 资助金额:
    $15.75万
  • 财政年份:
    2001
  • 负责人:
    WILLIAM NOWATZKE
  • 依托单位:
DISTINCTION AMONG EIGHT OPIATE DRUGS IN URINE BY GAS CHROMATOGRAPHIC
  • 批准号:
    6486751
  • 项目类别:
  • 资助金额:
    $15.75万
  • 财政年份:
    2001
  • 负责人:
    WILLIAM NOWATZKE
  • 依托单位:
MASS SPECTROMETRIC EVIDENCE AGENTS WHICH CAUSE CA2+ LOSS
  • 批准号:
    6336820
  • 项目类别:
  • 资助金额:
    $0.6万
  • 财政年份:
    2000
  • 负责人:
    WILLIAM NOWATZKE
  • 依托单位: